College of Medicine and Public Health

Activities

Activities per year 1974 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025

• 304 Invited talk
• 213 Other
• 194 Oral presentation
• 84 Participating in a conference, workshop, ...
• 170 More
  • 30 Membership of network
  • 28 Membership of committee
  • 23 Organising a conference, workshop, ...
  • 21 Editorial work
  • 20 Publication Peer-review
  • 16 Teaching activity
  • 10 Membership of board
  • 8 Visiting an external academic institution
  • 6 Consultancy
  • 3 Examination
  • 2 Membership of council
  • 2 Converted from research output
  • 1 Podcast appearance

Activities per year

Search results

• Work Health and Safety - Risk Management Module

  Matthews, S. (Participant)

  23 Sept 2014

  Activity: Other activity types › Other

• Supporting Diabetes Management in rural and remote Aboriginal medical services through on-site point of care testing

  Shephard, M. (Invited speaker)

  11 Oct 2014

  Activity: Talk or presentation types › Invited talk

• Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. Tricoci P, Lokhnygina Y, Huang Z, Van de Werf F, Cornel JH, Chen E, Wallentin L, Held C, Aylward PE, Moliterno DJ, Jennings LK, White HD, Armstrong PW, Harrington RA, Strony J, Mahaffey KW. Am Heart J. 2014 Dec;168(6):869-77.e1. doi: 10.1016/j.ahj.2014.09.002. Epub 2014 Sep 16. PMID: 25458650 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease. Rosser G, Tricoci P, Morrow D, Christopoulos C, Niespialowska-Steuden MN, Kozarski R, Wilcox R, Gorog DA. J Thromb Thrombolysis. 2014 Nov;38(4):423-9. doi: 10.1007/s11239-014-1075-4. PMID: 24676931 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. Held C, Tricoci P, Huang Z, Van de Werf F, White HD, Armstrong PW, Ambrosio G, Aylward PE, Moliterno DJ, Wallentin L, Chen E, Erkan A, Jiang L, Strony J, Harrington RA, Mahaffey KW. Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):246-56. doi: 10.1177/2048872614527838. Epub 2014 Mar 13. PMID: 24627331 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER). Jones WS, Tricoci P, Huang Z, Moliterno DJ, Harrington RA, Sinnaeve PR, Strony J, Van de Werf F, White HD, Held C, Armstrong PW, Aylward PE, Chen E, Patel MR, Mahaffey KW. Am Heart J. 2014 Oct;168(4):588-96. doi: 10.1016/j.ahj.2014.06.017. Epub 2014 Jul 4. PMID: 25262270 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• 74th Federation of International Pharmacists World Congress of Pharmacy and Pharmaceutical Sciences

  McKinnon, R. (Member of programme committee)

  16 Aug 2014 → 17 Aug 2014

  Activity: Participating in or organising an event types › Organising a conference, workshop, ...

• Pharmacogenomics and the future of pharmacy

  McKinnon, R. (Speaker)

  9 Oct 2014 → 11 Oct 2014

  Activity: Talk or presentation types › Invited talk

• Respirology and Case Report Journal

  Eastwood, P. (Invited speaker)

  17 May 2014

  Activity: Talk or presentation types › Invited talk

• Adelaide University Sciences Association (AUScA) (External organisation)

  Downes, C. (Member)

  Mar 2014 → Feb 2017

  Activity: Membership types › Membership of network

• WONCA Special Interest Group on global point-of-care testing

  Shephard, M. (Invited speaker)

  6 May 2014 → 8 May 2014

  Activity: Talk or presentation types › Invited talk

• 5th FIP Pharmaceutical Sciences World Congress

  McKinnon, R. (Chair)

  13 Apr 2014 → 16 Apr 2014

  Activity: Participating in or organising an event types › Organising a conference, workshop, ...

• Australasian Association of Clinical Biochemists (External organisation)

  Markus, C. (Member)

  2014 → 2019

  Activity: Membership types › Membership of committee

• Developing Motivational Interviewing skills for clinical educators and practitioners: Training with virtual patients

  Schoo, A. (Speaker), Leibbrandt, R. (Speaker), Litt, J. (Speaker), Lawn, S. (Speaker) & Luerssen, M. (Speaker)

  7 Jul 2014

  Activity: Talk or presentation types › Oral presentation

• Motivational Interviewing in chronic disease management: Preparing for clinical practice and supervision through reflective practice

  Schoo, A. (Speaker), Lawn, S. (Speaker), Litt, J. (Speaker), Luerssen, M. (Speaker) & Leibbrandt, R. (Speaker)

  7 Jul 2014

  Activity: Talk or presentation types › Oral presentation

• Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9. PMID: 24402559 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Coronary artery disease: Darapladib fails to improve the STABILITY of CAD. Roberts A. Nat Rev Cardiol. 2014 Jun;11(6):310. doi: 10.1038/nrcardio.2014.50. Epub 2014 Apr 15. PMID: 24736761

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Chronic disease management translation: implementation models and the Flinders Program

  Battersby, M. (Speaker), Harris, M. (Speaker), Lawn, S. (Speaker) & Morello, A. (Speaker)

  12 Nov 2014

  Activity: Talk or presentation types › Oral presentation

• New antithrombotics for secondary prevention of acute coronary syndrome. Goto S, Tomita A. Clin Cardiol. 2014 Mar;37(3):178-87. doi: 10.1002/clc.22233. Epub 2014 Jan 22. PMID: 24452610 Review.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER. White HD, Huang Z, Tricoci P, Van de Werf F, Wallentin L, Lokhnygina Y, Moliterno DJ, Aylward PE, Mahaffey KW, Armstrong PW. J Am Heart Assoc. 2014 Jul 10;3(4):e001032. doi: 10.1161/JAHA.114.001032. PMID: 25012288. Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Providing POCT training and competency for health professionals – experiences in remote Australia

  Shephard, M. (Invited speaker)

  12 Feb 2014

  Activity: Talk or presentation types › Invited talk

• Social accountability: frictions and cohesion between health professional councils, associations and civic organizations

  Baum, F. (Speaker)

  27 Jan 2014 → 29 Jan 2014

  Activity: Talk or presentation types › Invited talk

• Australasian Association of Clinical Biochemists (External organisation)

  Matthews, S. (Member)

  1 Jul 2014 → 30 Jun 2015

  Activity: Membership types › Membership of network

• Australian Corneal Graft Registry report 2014

  Keane, M. (Speaker)

  Mar 2014

  Activity: Talk or presentation types › Oral presentation

• Irish Hand Society Meeting, Belfast

  Bain, G. (Speaker)

  7 May 2014 → 11 May 2014

  Activity: Talk or presentation types › Invited talk

• 3 OR 4 Corner Fusion: Educational Video

  Bain, G. (Participant)

  2014 → 2025

  Activity: Other activity types › Teaching activity

• Interprofessional education and supervision: How is it enacted in the clinical workplace and what is the impact on professional identity?

  Kumar, K. (Speaker), Schoo, A. (Speaker), George, S. (Speaker), Lawn, S. (Speaker) & McAllister, S. (Speaker)

  7 Jul 2014

  Activity: Talk or presentation types › Oral presentation

• Biologics, the new frontier of medicines

  McKinnon, R. (Speaker)

  9 Oct 2014 → 11 Oct 2014

  Activity: Talk or presentation types › Invited talk

• Increasing global capacity to improve diabetes care for Indigenous Peoples through point-of-care testing

  Motta, L. (Speaker) & Shephard, M. (Speaker)

  27 Oct 2014 → 30 Oct 2014

  Activity: Talk or presentation types › Oral presentation

• Australasian Association of Clinical Biochemists (AACB) 52nd Annual Scientific Conference

  Matthews, S. (Participant)

  27 Oct 2014 → 29 Oct 2014

  Activity: Participating in or organising an event types › Participating in a conference, workshop, ...

• The future of biologicals: biosimilars and antibody drug conjugates

  McKinnon, R. (Speaker)

  11 Sept 2014 → 14 Sept 2014

  Activity: Talk or presentation types › Invited talk

• Unmet needs in drug discovery: what are the issues?

  McKinnon, R. (Speaker)

  31 Aug 2014 → 30 Sept 2014

  Activity: Talk or presentation types › Invited talk

• Worker and patient moral framings of community treatment orders

  Lawn, S. (Speaker), Delany, T. (Speaker), Pulvirenti, M. (Speaker) & McMillan, J. (Speaker)

  14 Dec 2014

  Activity: Talk or presentation types › Oral presentation

• Consumer participation in mental health

  Lawn, S. (Speaker)

  23 Nov 2014 → 25 Nov 2014

  Activity: Talk or presentation types › Oral presentation

• Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ. Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18. PMID: 25129064 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial). Mahaffey KW, Huang Z, Wallentin L, Storey RF, Jennings LK, Tricoci P, White HD, Armstrong PW, Aylward PE, Moliterno DJ, Van de Werf F, Chen E, Leonardi S, Rorick T, Held C, Strony J, Harrington RA. Am J Cardiol. 2014 Mar 15;113(6):936-44. doi: 10.1016/j.amjcard.2013.11.052. Epub 2013 Dec 25. PMID: 24444781 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Darapladib for preventing ischemic events in stable coronary heart disease. STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30. PMID: 24678955 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase. Marathe GK, Pandit C, Lakshmikanth CL, Chaithra VH, Jacob SP, D'Souza CJ. J Lipid Res. 2014 Sep;55(9):1847-54. doi: 10.1194/jlr.R045492. Epub 2014 May 23. PMID: 24859738. Review.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka GD, Held C, Nicolau JC, Storey RF, Ruzyllo W, Huber K, Sinnaeve P, Weiss AT, Dery JP, Moliterno DJ, Van de Werf F, Aylward PE, White HD, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW. J Am Coll Cardiol. 2014 Mar 25;63(11):1048-57. doi: 10.1016/j.jacc.2013.10.048. Epub 2013 Nov 21. PMID: 24211500 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• An overview or point-of-care testing and the TTANGO Trial

  Shephard, M. (Invited speaker)

  5 Nov 2014

  Activity: Talk or presentation types › Invited talk

• The influence of storage medium on corneal graft outcomes

  Keane, M. (Speaker)

  Mar 2014

  Activity: Talk or presentation types › Oral presentation

• NZOA COE, and NZHSS, Queenstown, New Zealand

  Bain, G. (Speaker)

  12 Apr 2014 → 16 Apr 2014

  Activity: Talk or presentation types › Invited talk

• Deep sequencing of mouse models recapitulating disorders of sex development identifies candidate genes.

  Lavery, R. (Speaker)

  19 Feb 2014 → 22 Feb 2014

  Activity: Talk or presentation types › Oral presentation

• Electrical stimulation of the hypoglossal nerve in the treatment of OSA

  Eastwood, P. (Invited speaker)

  2013

  Activity: Talk or presentation types › Invited talk

• Structural Violence, Neo-liberalism and public health: impacts on health and what structures might create healthier and more equitable societies

  Baum, F. (Speaker)

  13 Nov 2013

  Activity: Talk or presentation types › Invited talk

• Walk a mile in my shoes: reflective peer-to-peer dialogues within the eLearning space

  Lawn, S. (Speaker)

  26 Jul 2013

  Activity: Talk or presentation types › Oral presentation

• Too-hard basket or health for all? Getting to know NZ smokers with mental health issues

  McGough, S. (Speaker) & Lawn, S. (Speaker)

  23 Oct 2013

  Activity: Talk or presentation types › Oral presentation

• Achieving smoke-free mental health services: how far have we come and what obstacles remain?

  Lawn, S. (Speaker) & Campion, J. (Speaker)

  23 Oct 2013 → 25 Oct 2013

  Activity: Talk or presentation types › Oral presentation

• Psychosocial support in mental illness: Creating change to improve services

  Harris, M. (Speaker), Jones, P. (Speaker), Heartfield, M. (Speaker), Allstrom, M. (Speaker), Hancock, J. (Speaker), Lawn, S. (Speaker) & Battersby, M. (Speaker)

  13 Jun 2013 → 3 Jul 2013

  Activity: Talk or presentation types › Oral presentation

• Triazole derivatives: a series of Darapladib analogues as orally active Lp-PLA2 inhibitors. Wang K, Xu W, Zhang W, Mo M, Wang Y, Shen J. Bioorg Med Chem Lett. 2013 May 15;23(10):2897-901. doi: 10.1016/j.bmcl.2013.03.062. Epub 2013 Mar 26. PMID: 23575276

  Morton, E. (Other)

  2013

  Activity: Other activity types › Other